Ginkgo Bioworks Holdings, Inc. (DNA) NYSE
7.81
-0.63(-7.46%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.81
-0.63(-7.46%)
Currency In USD
| Market Cap | 460.85M |
| Enterprise Value | 710.73M |
| P/E Ratio | -1.38 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 2.84 |
| Price/Book Ratio | 0.85 |
| Enterprise/Revenue | 4.31 |
| Enterprise/EBITDA | -3.4 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.84 |
| Operating Margin | -1.85 |
| Return On Assets | -0.28 |
| Return On Equity | -0.54 |
| Revenue | 170.16M |
| Revenue/Share | 3.07 |
| Gross Profit | 138.63M |
| EBITDA | -254.61M |
| Net Income | -312.76M |
| Diluted EPS | -5.64 |
| Total Cash | 422.62M |
| Total Cash/Share | 7.62 |
| Total Debt | 417.08M |
| Total Debt/Equity | 0.82 |
| Current Ratio | 4.92 |
| Book Value Per Share | 9.17 |
| 52-Week Change | 2.76 |
| 52-Week High | 17.58 |
| 52-Week Low | 5.37 |
| Moving Average 50 Days | 7.46 |
| Moving Average 200 Days | 10.12 |
| Average Volume | 1.19M |
| Shares Outstanding | 61.92M |
| % Held by Institutions | 58.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | August 20, 2024 |